• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

机器人辅助同期双侧肾肿瘤部分切除术的初步经验——单中心分析。

Pilot experience of simultaneous robotic-assisted partial nephrectomy for bilateral renal tumors-single center analysis.

机构信息

Department of Urology, Osaka City University Graduate School of Medicine, Osaka, Japan.

出版信息

Asian J Endosc Surg. 2021 Jan;14(1):57-62. doi: 10.1111/ases.12831. Epub 2020 Jun 29.

DOI:10.1111/ases.12831
PMID:32602220
Abstract

INTRODUCTION

Bilateral renal tumors accounts for approximately 3% of renal tumors. However, surgical treatment methods for bilateral renal tumors have not yet been established. It is imperative to balance the need for curative surgery with the goal of maximal functional preservation in patients with bilateral synchronous renal tumors. Therefore, partial nephrectomy may be the optimal surgical treatment for bilateral synchronous renal tumors.

METHODS

We conducted a retrospective, observational study to analyze the clinical outcome of simultaneous robotic-assisted partial nephrectomy (RAPN) for bilateral renal tumors at our institution between 2016 and 2019. A total of eight patients were enrolled and the number of renal masses in the 16 kidneys was 18.

RESULTS

There was no positive surgical margin after RAPN in our case series and no local recurrence or metastasis during the follow-up period. The only complication of simultaneous RAPN in the present case series was that one patient experienced acute kidney injury after operation without need for dialysis therapy.

CONCLUSION

Our study suggests that simultaneous RAPN for bilateral renal tumors might be feasible both for the preservation of renal function and for oncological outcome such as negative surgical margin.

摘要

介绍

双侧肾脏肿瘤约占肾脏肿瘤的 3%。然而,双侧肾脏肿瘤的手术治疗方法尚未确定。在双侧同时性肾脏肿瘤患者中,平衡根治性手术的需求与最大限度保留肾功能的目标至关重要。因此,部分肾切除术可能是双侧同时性肾脏肿瘤的最佳手术治疗方法。

方法

我们进行了一项回顾性观察研究,分析了 2016 年至 2019 年间我院同期行机器人辅助部分肾切除术(RAPN)治疗双侧肾脏肿瘤的临床疗效。共纳入 8 例患者,16 个肾脏的肾肿瘤数量为 18 个。

结果

在我们的病例系列中,RAPN 后无肿瘤切缘阳性,随访期间无局部复发或转移。本病例系列中同期 RAPN 的唯一并发症是 1 例患者术后发生急性肾损伤,无需透析治疗。

结论

我们的研究表明,同期 RAPN 治疗双侧肾脏肿瘤既能保留肾功能,又能获得阴性手术切缘等肿瘤学结果。

相似文献

1
Pilot experience of simultaneous robotic-assisted partial nephrectomy for bilateral renal tumors-single center analysis.机器人辅助同期双侧肾肿瘤部分切除术的初步经验——单中心分析。
Asian J Endosc Surg. 2021 Jan;14(1):57-62. doi: 10.1111/ases.12831. Epub 2020 Jun 29.
2
Robot-assisted Partial Nephrectomy for Complex (PADUA Score ≥10) Tumors: Techniques and Results from a Multicenter Experience at Four High-volume Centers.机器人辅助部分肾切除术治疗复杂(PADUA 评分≥10)肿瘤:四个高容量中心的多中心经验中的技术和结果。
Eur Urol. 2020 Jan;77(1):95-100. doi: 10.1016/j.eururo.2019.03.006. Epub 2019 Mar 19.
3
Simultaneous totally robotic rectal resection and partial nephrectomy: case report and review of literature.同期全机器人直肠切除术和部分肾切除术:病例报告和文献复习。
World J Surg Oncol. 2020 May 4;18(1):86. doi: 10.1186/s12957-020-01864-1.
4
Transperitoneal Robot-assisted Partial Nephrectomy with Minimum Follow-up of 5 Years: Oncological and Functional Outcomes from a Single Institution.经腹腔机器人辅助部分肾切除术:单中心 5 年以上随访的肿瘤学和功能结果。
Eur Urol Oncol. 2019 Mar;2(2):207-213. doi: 10.1016/j.euo.2018.06.012. Epub 2018 Jul 14.
5
Robotic versus open partial nephrectomy for highly complex renal masses: Comparison of perioperative, functional, and oncological outcomes.机器人辅助与开放性部分肾切除术治疗高度复杂肾肿物:围手术期、功能及肿瘤学结局的比较
Urol Oncol. 2018 Oct;36(10):471.e1-471.e9. doi: 10.1016/j.urolonc.2018.06.012. Epub 2018 Aug 9.
6
Robot-assisted Partial Nephrectomy: 5-yr Oncological Outcomes at a Single European Tertiary Cancer Center.机器人辅助部分肾切除术:单一欧洲三级癌症中心的 5 年肿瘤学结果。
Eur Urol Focus. 2019 Jul;5(4):636-641. doi: 10.1016/j.euf.2017.10.005. Epub 2017 Oct 27.
7
Simultaneous robotic partial nephrectomy for bilateral renal masses.同期机器人辅助双侧肾脏肿瘤部分切除术。
World J Urol. 2022 Apr;40(4):1005-1010. doi: 10.1007/s00345-021-03919-8. Epub 2022 Jan 9.
8
Outcomes of Robot-assisted Partial Nephrectomy for Clinical T2 Renal Tumors: A Multicenter Analysis (ROSULA Collaborative Group).机器人辅助部分肾切除术治疗 T2 期临床肾肿瘤的结果:多中心分析(ROSULA 协作组)。
Eur Urol. 2018 Aug;74(2):226-232. doi: 10.1016/j.eururo.2018.05.004. Epub 2018 May 19.
9
Robot-Assisted Partial Nephrectomy for Totally Endophytic Renal Tumors: Step by Step Standardized Surgical Technique and Long-Term Outcomes with a Median 59-Month Follow-Up.机器人辅助部分肾切除术治疗完全内生性肾肿瘤:逐步标准化手术技术及中位随访59个月的长期结果
J Laparoendosc Adv Surg Tech A. 2019 Jan;29(1):1-11. doi: 10.1089/lap.2018.0124. Epub 2018 Oct 9.
10
Robotic Partial Nephrectomy for Bilateral Renal Masses.双侧肾肿块的机器人辅助部分肾切除术
Curr Urol Rep. 2023 Apr;24(4):157-163. doi: 10.1007/s11934-022-01143-4. Epub 2022 Dec 20.

引用本文的文献

1
DaVinci SP-based simultaneous bilateral partial nephrectomy from the midline transperitoneal approach: a case report.基于达芬奇SP系统经中线经腹途径的同期双侧部分肾切除术:一例报告
J Yeungnam Med Sci. 2024 Jan;41(1):48-52. doi: 10.12701/jyms.2023.01032. Epub 2024 Jan 4.
2
A systematic review of robot-assisted partial nephrectomy outcomes for advanced indications: Large tumors (cT2-T3), solitary kidney, completely endophytic, hilar, recurrent, and multiple renal tumors.晚期适应症的机器人辅助部分肾切除术结果的系统评价:大肿瘤(cT2-T3)、孤立肾、完全内生性、肾门、复发性和多发性肾肿瘤。
Asian J Urol. 2023 Oct;10(4):390-406. doi: 10.1016/j.ajur.2023.06.001. Epub 2023 Aug 1.
3
The current evidence on surgical management for synchronous bilateral renal tumors: results from a scoping review.
目前关于同期双侧肾肿瘤的外科治疗的证据:来自范围综述的结果。
World J Urol. 2023 Aug;41(8):2107-2118. doi: 10.1007/s00345-023-04503-y. Epub 2023 Jul 5.
4
Robotic Partial Nephrectomy for Bilateral Renal Masses.双侧肾肿块的机器人辅助部分肾切除术
Curr Urol Rep. 2023 Apr;24(4):157-163. doi: 10.1007/s11934-022-01143-4. Epub 2022 Dec 20.
5
Simultaneous robotic partial nephrectomy for bilateral renal masses.同期机器人辅助双侧肾脏肿瘤部分切除术。
World J Urol. 2022 Apr;40(4):1005-1010. doi: 10.1007/s00345-021-03919-8. Epub 2022 Jan 9.